December 25, 2014 8:36 AM ET

Biotechnology

Company Overview of Fusion IP plc

Company Overview

Fusion IP plc, through its subsidiaries, commercializes intellectual property (IP) that is developed at universities and similar establishments through the formation of, and investment in, spin-out companies in the United Kingdom. It has agreements with the University of Sheffield, the Cardiff University, the University of Nottingham, and Swansea University. The company also has a portfolio of approximately 20 companies in a range of engineering, nanotechnology, software, and medical sectors. In addition, it develops orphan drugs, cancer diagnostics and therapeutics, advanced wound care, novel new pharmaceuticals, and antibody therapies, as well as is involved in designing and testing micron...

The Sheffield Bioincubator

40 Leavygreave Road

Sheffield,  S3 7RD

United Kingdom

15 Employees

Key Executives for Fusion IP plc

Operations Director and Director
Age: 55
Company Secretary
Commercial Director and Director
Age: 51
Compensation as of Fiscal Year 2014.

Fusion IP plc Key Developments

Fusion IP plc Reports Preliminary Consolidated Earnings Results for the Full Year Ended July 31, 2013

Fusion IP plc reported preliminary consolidated earnings results for the full year ended July 31, 2013. Total revenue and portfolio returns decreased to £3,035,000 from £4,750,000 last year, due to both a reduction in revenue and fewer funding rounds leading to lower net fair value gains on investments. Revenue, which includes the amounts charged to non-subsidiary spin-out companies for management services provided, license income and income generated by consolidated companies, decreased to £540,000 from £705,000 reported last year. The decrease relates to reduced revenue in subsidiaries. Loss from operating activities was £1,366,000 against income from operating activities of £390,000 last year. Loss before taxation was £1,204,000 against profit before taxation of £505,000 last year. The group generated an operating profit (excluding subsidiary spin-out costs and amortization) of £1,250,000 against £3,042,000 last year. Loss and total comprehensive loss attributable to owners of the parent was £959,000 or 1.14 pence per basic and diluted share against profit and total comprehensive profit attributable to owners of the parent of £669,000 or 1.00 pence per basic and diluted share last year. Net cash flows used in operating activities was £1,908,000 against £2,066,000 last year. Purchase of property, plant and equipment was £12,000 against £8,000 last year.

Fusion IP plc to Report Fiscal Year 2013 Results on Oct 15, 2013

Fusion IP plc announced that they will report fiscal year 2013 results on Oct 15, 2013

Fusion IP plc Announces Unaudited Consolidated Earnings Results for the Six Months Ended January 31, 2013

Fusion IP plc announced its unaudited consolidated earnings results for the six months ended January 31, 2013. For the period, the company reported revenue of £288,000, loss from operating activities of £1,940,000, loss before taxation of £1,853,000 and loss attributable to owners of the parent of £1,724,000 or 2.37 pence per basic and fully diluted share compared with revenue of £313,000, loss from operating activities of £1,760,000, loss before taxation of £1,701,000 and loss attributable to owners of the parent of £1,623,000 or 2.69 pence per basic and fully diluted share a year ago period. Net cash outflow from operating activities was £824,000 against £939,000 a year ago period. Purchase of property, plant and equipment was £4,000 against £5,000 a year ago period. Excluding the amortisation of intangible assets, the Group achieved an underlying loss from operating activities of £946,000 compared to a loss of £765,000 for the six months ended 31 January 2012. The movement in reported losses mainly arose from additional spin out expenses due to new subsidiary companies.

Similar Private Companies By Industry

Company Name Region
Novacta Biosystems Limited Europe
Ubiquigent Ltd. Europe
CN Bio Innovations Ltd Europe
Piramed Limited Europe
Sterix Limited Europe

Recent Private Companies Transactions

Type
Date
Target
Private Placement
April 8, 2014
Seren Photonics Limited
Merger/Acquisition
January 23, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Fusion IP plc, please visit www.biofusion.co.uk. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.